Nektar Therapeutics
NKTR
Delayed Nasdaq - 04/25 10:00:00 pm
82.59USD
-2.27%
Upcoming events
04/28/18 | 03:00
American Academy of Pain Medicine Meeting
05/08/18 | 14:40
Deutsche Bank Health Care Conference
05/09/18
Q1 2018 Earnings Release (Projected)
05/24/18 | 18:40
Advances in Immuno-Oncology Congress
Past Events
04/17/18 | 03:00pmAmerican Association for Cancer Research Meeting - Abstract - 3566
04/17/18 | 03:00pmAmerican Association for Cancer Research Meeting - Abstract - 3755
04/16/18 | 08:00pmAmerican Association for Cancer Research Meeting - Abstract - 2755
04/15/18 | 08:00pmAmerican Association for Cancer Research Meeting - Abstract - 123
Annual results
Annual results20172018 (e)
Sales
Million $
Released
Forecast
Spread
308
249
24%

540
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-28,9
-88,0
67%

337
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-43,7
-81,3
46%

57,2
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
-96,7
-119
19%

27,0
EPS
 $
Released
Forecast
Spread
-0,62
-0,76
19%

0,00
Announcement Date03/01/2018
Quarterly / Semiannualy publications
Quarterly resultsQ4
2017
Q1
2018 (e)
Sales
Million $
Released
Forecast
Spread
95,5
37,0
158%

141
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-5,39
53,0
-110%

460
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-8,05
-30,6
74%

43,3
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
-33,8
-38,4
12%

48,1
EPS
 $
Released
Forecast
Spread
-0,21
-0,35
40%

0,09
Announcement Date03/01/2018
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise